2.31
Schlusskurs vom Vortag:
$2.08
Offen:
$2.07
24-Stunden-Volumen:
236.47K
Relative Volume:
1.86
Marktkapitalisierung:
$231.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.14M
KGV:
-3.2558
EPS:
-0.7095
Netto-Cashflow:
$-68.17M
1W Leistung:
+12.68%
1M Leistung:
+22.87%
6M Leistung:
-14.76%
1J Leistung:
-36.63%
Ac Immune Sa Stock (ACIU) Company Profile
Vergleichen Sie ACIU mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ACIU
Ac Immune Sa
|
2.31 | 206.23M | 0 | -60.14M | -68.17M | -0.7095 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-05-31 | Eingeleitet | BTIG Research | Buy |
2019-02-01 | Herabstufung | UBS | Buy → Neutral |
2019-01-04 | Eingeleitet | UBS | Buy |
2018-04-05 | Eingeleitet | H.C. Wainwright | Buy |
2018-03-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
2016-10-18 | Eingeleitet | Credit Suisse | Outperform |
2016-10-18 | Eingeleitet | Jefferies | Buy |
2016-10-18 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Ac Immune Sa Aktie (ACIU) Neueste Nachrichten
What analysts say about AC Immune SA stockUnprecedented growth rates - Autocar Professional
Is AC Immune SA a good long term investmentConsistently profitable trades - jammulinksnews.com
AC Immune SA Stock Analysis and ForecastExceptional risk-adjusted gains - jammulinksnews.com
What drives AC Immune SA stock priceConsistently high returns - jammulinksnews.com
AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech
How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser
Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser
What makes AC Immune SA stock price move sharplyFree Access to Community - Newser
Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune SA Announces Executive Changes - MarketScreener
AC Immune SA Announces Leadership Changes in Development Team - TipRanks
AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st
Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World
Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World
Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World
June 2025 Penny Stocks With Promising Potential - simplywall.st
Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World
Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com
Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World
Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st
TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient
Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN
AC Immune (ACIU) to Release Earnings on Monday - Defense World
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune (NASDAQ:ACIU) Downgraded by StockNews.com to “Hold” - Defense World
Equities Analysts Issue Forecasts for AC Immune Q2 Earnings - Defense World
Finanzdaten der Ac Immune Sa-Aktie (ACIU)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):